Weldon, K. S. | bioRxiv Science

bioRxiv2026

Bronchus associated lymphoid tissue induced by an attenuated Mycobacterium tuberculosis vaccine prevents tuberculosis from heterologous TB challenge

Tuberculosis (TB) remains a leading cause of death from infectious disease worldwide, underscoring the urgent need for vaccines with greater and more consistent efficacy than Bacille Calmette-Guerin (BCG). We previously showed that mucosal vaccination with an isogenic Mycobacterium tuberculosis (Mtb) mutant lacking the stress-response transcription factor SigH ({Delta}sigH) prevents pulmonary TB in two macaque species. In the absence of SigH, Mtb is unable to effectively counter host oxidative stress. Vaccinated macaques were notably protected from disease, exhibiting an absence of granulomatous pathology together with the formation of lymphoid follicles and robust antigen-specific CD4+ and CD8+ T cell responses, identifying{Delta} sigH as a promising live-attenuated TB vaccine candidate. The{Delta} sigH mutant used in prior studies was generated in the Mtb CDC1551 background, a commonly used laboratory strain for challenge studies. Here, we evaluated whether{Delta} sigH-mediated protection extends to heterologous challenge with the more virulent Mtb Erdman strain. Mucosal{Delta} sigH vaccination conferred significant protection against heterologous challenge, markedly reducing pulmonary bacterial burden and TB-associated pathology. Longitudinal high-resolution PET/CT imaging demonstrated that aerosol{Delta} sigH vaccination induced robust inducible bronchus-associated lymphoid tissue (iBALT) responses in the lung. Unlike granulomas, these iBALT structures resolved over time while remaining associated with protection against subsequent Mtb challenge. Protection of highly susceptible rhesus macaques against virulent heterologous Mtb challenge following aerosol{Delta} sigH vaccination supports the further preclinical development of{Delta} sigH-based live-attenuated TB vaccines and highlights iBALT induction as a potential correlate and mechanistic driver of protective immunity against TB.

immunology↗

bioRxiv2025

Hybridization Reveals Cell Type-Specific Regulatory Variation Driving Brain Transcriptomic Divergence

Gene expression is a molecular trait that can cumulatively contribute to more complex phenotypes. Interspecies hybrids have long been used to study the genetics basis of molecular, morphological and behavioral traits, to dissect interactions between cis- and trans-regulators with parental traits, and to uncover incompatible genetic interactions that drive extreme phenotypes in hybrid progeny. However, it remains unclear how organ functions at molecular level are affected by hybridization. We hypothesize that hybridization incited molecular level changes are cell type specific. To test this, we produced interspecies hybrid progeny from two distantly related fish species, Xiphophorus maculatus and couchianus. They are differing in mating, foraging behavior and likely neural circuits for cognition. We first performed allelic expression and bulk brain transcriptome profiling to identify expression quantitative trait loci (eQTLs) and quantitative transcript traits (QTTs) in order to quantify the scale and identify of loci contributing to gene expression variations in hybrids. It showed that QTT are predominantly influenced by additive eQTLs. Subsequently, we compared QTTs, which exemplify species-specific regulatory effects on gene expression, to cell type markers derived from single-nucleus RNA sequencing (snRNAseq). We identified 14 cell type-specific QTTs with known roles in brain functions. Overall, this study shows that transcriptomic phenotypes under species-specific regulators are associated to specific cell types in hybrids, and indicates the overall organ-level functional change could be driven by particular cell types.

genetics↗